Analysis of the Final DENALI Trial Data: A Prospective, Multicenter Study of the Denali Inferior Vena Cava Filter

Journal of Vascular and Interventional Radiology

Volumn 27, Issue 10, 2016, Pages 1531-1538.e1

  Stavropoulos, S William ^a   Chen, James X ^a   Sing, Ronald F ^c   Elmasri, Fakhir ^d   Silver, Mitchell J ^e   Powell, Alex ^f   Lynch, Frank C ^b   Abdel Aal, Ahmed Kamel ^g   Lansky, Alexandra ^h   Muhs, Bart E ⁱ  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

^d LAKELAND REGIONAL MEDICAL CENTER   (United States)

^e RIVERSIDE METHODIST HOSPITAL   (United States)

^f BAPTIST HOSPITAL OF MIAMI   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Vascular Experts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL; ALLOY;

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEVICE MIGRATION; DEVICE SAFETY; FEMALE; FOLLOW UP; FRACTURE; HUMAN; IMPLANTATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; TREATMENT INDICATION; VENA CAVA FILTER; ADVERSE EFFECTS; CLINICAL TRIAL; COMPLICATION; DEVICE REMOVAL; DEVICES; DIAGNOSTIC IMAGING; INFERIOR CAVA VEIN; MIDDLE AGED; PHLEBOGRAPHY; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; PULMONARY EMBOLISM; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOSIS;

ADULT; AGED; ALLOYS; DEVICE REMOVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHLEBOGRAPHY; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; PULMONARY EMBOLISM; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VENA CAVA FILTERS; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 84994099391     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2016.06.028     Document Type: Article

References (26)

1. 1 Decousus, H., Leizorovicz, A., Parent, F., et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338 (1998), 409–415.
2. 2 Spencer, F.A., Emery, C., Lessard, D., et al. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 21 (2006), 722–727.
3. 3 Kearon, C., Akl, E.A., Comerota, A.J., et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141 (2012), e419S–e494S.
4. 4 Caplin, D.M., Nikolic, B., Kalva, S.P., et al. Quality improvement guidelines for the performance of inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol 22 (2011), 1499–1506.
5. 5 Stavropoulos, S.W., Sing, R.F., Elmasri, F., et al. The DENALI trial: an interim analysis of a prospective, multicenter study of the Denali retrievable inferior vena cava filter. J Vasc Interv Radiol 25 (2014), 1497–1505 e1.
6. 6 Grassi, C.J., Swan, T.L., Cardella, J.F., et al. Quality improvement guidelines for percutaneous permanent inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol 14 (2003), S271–S275.
7. 7 Millward, S.F., Grassi, C.J., Kinney, T.B., et al. Reporting standards for inferior vena caval filter placement and patient follow-up: supplement for temporary and retrievable/optional filters. J Vasc Interv Radiol 20 (2009), S374–S376.
8. 8 Sacks, D., McClenny, T.E., Cardella, J.F., Lewis, C.A., Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14 (2003), S199–S202.
9. 9 Vena Caval Filter Consensus Conference. Recommended reporting standards for vena caval filter placement and patient follow-up. J Vasc Interv Radiol 14 (2003), S427–S432.
10. 10 Binkert, C.A., Drooz, A.T., Caridi, J.G., et al. Technical success and safety of retrieval of the G2 filter in a prospective, multicenter study. J Vasc Interv Radiol 20 (2009), 1449–1453.
11. 11 Johnson, M.S., Nemcek, A.A. Jr, Benenati, J.F., et al. The safety and effectiveness of the retrievable option inferior vena cava filter: a United States prospective multicenter clinical study. J Vasc Interv Radiol 21 (2010), 1173–1184.
12. 12 Lyon, S.M., Riojas, G.E., Uberoi, R., et al. Short- and long-term retrievability of the celect vena cava filter: results from a multi-institutional registry. J Vasc Interv Radiol 20 (2009), 1441–1448.
13. 13 Smouse, H.B., Mendes, R., Bosiers, M., Van Ha, T.G., Crabtree, T, RETRIVE Investigators. The RETRIEVE trial: safety and effectiveness of the retrievable crux vena cava filter. J Vasc Interv Radiol 24 (2013), 609–621.
14. 14 Andreoli, J.M., Lewandowski, R.J., Vogelzang, R.L., Ryu, R.K., Comparison of complication rates associated with permanent and retrievable inferior vena cava filters: a review of the MAUDE database. J Vasc Interv Radiol 25 (2014), 1181–1185.
15. 15 Jia, Z., Wu, A., Tam, M., Spain, J., McKinney, J.M., Wang, W., Caval penetration by inferior vena cava filters: a systematic literature review of clinical significance and management. Circulation 132 (2015), 944–952.
16. 16 Dowell, J.D., Castle, J.C., Schickel, M., et al. Celect inferior vena cava wall strut perforation begets additional strut perforation. J Vasc Interv Radiol 26 (2015), 1510–1518 e3.
17. 17 Oh, J.C., Trerotola, S.O., Dagli, M., et al. Removal of retrievable inferior vena cava filters with computed tomography findings indicating tenting or penetration of the inferior vena cava wall. J Vasc Interv Radiol 22 (2011), 70–74.
18. 18 Kuo, W.T., Robertson, S.W., Bard Denali inferior vena cava filter fracture and embolization resulting in cardiac tamponade: a device failure analysis. J Vasc Interv Radiol 26 (2015), 111–115 e1.
19. 19 US Food and Drug Administration. Inferior vena cava (IVC) filters: initial communication: risk of adverse events with long term use. 2010. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm221707.htm. Accessed August 18, 2016.
20. 20 US Food and Drug Administration. Removing retrievable inferior vena cava filters: FDA safety communication. 2014. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm396377.htm. Accessed August 18, 2016.
21. 21 Sarosiek, S., Crowther, M., Sloan, J.M., Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med 173 (2013), 513–517.
22. 22 Kuo, W.T., Robertson, S.W., Odegaard, J.I., Hofmann, L.V., Complex retrieval of fractured, embedded, and penetrating inferior vena cava filters: a prospective study with histologic and electron microscopic analysis. J Vasc Interv Radiol 24 (2013), 622–630.
23. 23 Stavropoulos, S.W., Ge, B.H., Mondschein, J.I., Shlansky-Goldberg, R.D., Sudheendra, D., Trerotola, S.O., Retrieval of tip-embedded inferior vena cava filters by using the endobronchial forceps technique: experience at a single institution. Radiology 275 (2015), 900–907.
24. 24 Ziegler, J.W., Dietrich, G.J., Cohen, S.A., Sterling, K., Duncan, J., Samotowka, M., PROOF trial: protection from pulmonary embolism with the OPTEASE filter. J Vasc Interv Radiol 19 (2008), 1165–1170.
25. 25 Smouse, H.B., Rosenthal, D., Thuong, V.H., et al. Long-term retrieval success rate profile for the gunther tulip vena cava filter. J Vasc Interv Radiol 20 (2009), 871–877 quiz 8.
26. 26 Mismetti, P., Rivron-Guillot, K., Quenet, S., et al. A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. Chest 131 (2007), 223–229.